{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:00:02Z","timestamp":1794693602896,"version":"4.9.1"},"reference-count":60,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"Tianfu Jincheng Laboratory, Sichuan University","award":["2025ZH003"],"award-info":[{"award-number":["2025ZH003"]}],"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Department of Science and Technology of Sichuan Province","award":["2025ZNSFSC0686"],"award-info":[{"award-number":["2025ZNSFSC0686"]}]},{"name":"National Health Commission Key Laboratory of Nuclear Technology Medical Transformation, Mianyang Central Hospital Mianyang Central Hospital","award":["2025HYX028"],"award-info":[{"award-number":["2025HYX028"]}],"id":[{"id":"https:\/\/ror.org\/00s528j33","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ectonucleotide pyrophosphatase\/phosphodiesterase 1 (ENPP1) hydrolyzes cGAMP within the tumor microenvironment (TME), suppressing stimulator of interferon genes (STING)-mediated antitumor immunity. Inspired by the phosphate-based inhibitor STF-1084, we developed a novel class of non-nucleotide ENPP1 inhibitors featuring a boronic acid zinc-binding group (ZBG), which led to the identification of the potent and pH-resilient compound 36. In vitro evaluations confirmed that compound 36 enhances cGAMP-mediated STING activation, driving the upregulation of key immune effectors and chemokines. Furthermore, in a syngeneic CT26 tumor model, monotherapy with compound 36 (20 mg\/kg, IP) achieved a tumor growth inhibition (TGI) of 57.4%. Notably, combination therapy with a single dose of oxaliplatin (OX) exhibited a synergistic antitumor effect (TGI = 80.7%) without observable toxicity. Collectively, this study identifies compound 36 as a promising lead ENPP1 inhibitor and further highlights boronic acid as an effective ZBG for the development of ENPP1-targeted cancer immunotherapies.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01649","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:01:55Z","timestamp":1791464515000},"page":"24096-24120","source":"Crossref","is-referenced-by-count":1,"title":["Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy"],"prefix":"10.1021","volume":"69","author":[{"given":"Ya-Ling","family":"Li","sequence":"first","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ling","family":"He","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Dong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Shi","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"He","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Qiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Wen","family":"Yang","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Chen","sequence":"additional","affiliation":[{"name":"Jiangxi Normal University , , , ,","place":["Nanchang, Jiangxi, China, 330022"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0718-1820","authenticated-orcid":true,"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[{"name":"Fudan University , , ,","place":["Shanghai, China, 200433"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4942-4501","authenticated-orcid":true,"given":"You-Cai","family":"Xiao","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-3388","authenticated-orcid":true,"given":"Fen-Er","family":"Chen","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Jiangxi Normal University , , ,","place":["Nanchang, China, 330022"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200433"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"11","key":"2026102305072758400_cit1","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/ni1528","article-title":"Pathogen Subversion of Cell-Intrinsic Innate Immunity","volume":"8","author":"Roy","year":"2007","journal-title":"Nat. Immunol."},{"issue":"2","key":"2026102305072758400_cit2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate Immunity: The First Line of Defense against SARS-CoV-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat. Immunol."},{"issue":"5","key":"2026102305072758400_cit3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer Immune Evasion, Immunoediting and Intratumour Heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"6121","key":"2026102305072758400_cit4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"issue":"5","key":"2026102305072758400_cit5","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","article-title":"Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity","volume":"29","author":"Schadt","year":"2019","journal-title":"Cell Rep."},{"issue":"9","key":"2026102305072758400_cit6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","article-title":"Role of the cGAS-STING Pathway in Systemic and Organ-Specific Diseases","volume":"18","author":"Skopelja-Gardner","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"9","key":"2026102305072758400_cit7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING Pathway as a Therapeutic Target in Inflammatory Diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"16","key":"2026102305072758400_cit8","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The Tumor Microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"2026102305072758400_cit9","doi-asserted-by":"publisher","first-page":"113603","DOI":"10.1016\/j.jconrel.2025.113603","article-title":"Myeloid-Derived Suppressor Cell-Targeted Virus-like Particles Synergistically Activate Innate Immune Response for Cancer Immunotherapy","volume":"381","author":"Zhu","year":"2025","journal-title":"J. Control. Release"},{"issue":"5","key":"2026102305072758400_cit10","doi-asserted-by":"publisher","first-page":"101150","DOI":"10.1016\/j.jpha.2024.101150","article-title":"Targeting Tumor Metabolism to Augment CD8+ T Cell Anti-Tumor Immunity","volume":"15","author":"Liu","year":"2025","journal-title":"J. Pharm. Anal."},{"issue":"1","key":"2026102305072758400_cit11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS-STING Pathway in Cancer Immunity: Mechanisms, Challenges, and Therapeutic Implications","volume":"18","author":"Shen","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"2026102305072758400_cit12","doi-asserted-by":"publisher","first-page":"103105","DOI":"10.1016\/j.copbio.2024.103105","article-title":"Delivery of STING Agonists for Cancer Immunotherapy","volume":"87","author":"Wang","year":"2024","journal-title":"Curr. Opin. Biotech."},{"issue":"2","key":"2026102305072758400_cit13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1432-1033.1975.tb03935.x","article-title":"Nucleotide Pyrophosphatase of Rat Liver. A Comparative Study on the Enzymes Solubilized and Purified from Plasma Membrane and Endoplasmic Reticulum","volume":"51","author":"Bischoff","year":"1975","journal-title":"Eur. J. Biochem."},{"issue":"12","key":"2026102305072758400_cit14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2\u20193\u2019-cGAMP by ENPP1 and Design of Nonhydrolyzable Analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"2026102305072758400_cit15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s43018-020-0028-4","article-title":"Extracellular cGAMP Is a Cancer-Cell-Produced Immunotransmitter Involved in Radiation-Induced Anticancer Immunity","volume":"1","author":"Carozza","year":"2020","journal-title":"Nat. Cancer"},{"issue":"9","key":"2026102305072758400_cit16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-020-0304-7","article-title":"Conversion of Extracellular ATP into Adenosine: A Master Switch in Renal Health and Disease","volume":"16","author":"Dwyer","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"2026102305072758400_cit17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-immunol-051116-052406","article-title":"Purine Release, Metabolism, and Signaling in the Inflammatory Response","volume":"37","author":"Linden","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"2026102305072758400_cit18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.tcb.2021.05.008","article-title":"The Elegant Complexity of Mammalian Ecto-5\u2032-Nucleotidase (CD73)","volume":"31","author":"Alcedo","year":"2021","journal-title":"Trends Cell Biol."},{"issue":"12","key":"2026102305072758400_cit19","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1158\/1078-0432.ccr-22-1681","article-title":"ENPP1 Immunobiology as a Therapeutic Target","volume":"29","author":"Ruiz-Ferna\u0301ndez de Co\u0301rdoba","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"2026102305072758400_cit20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.clineuro.2010.11.018","article-title":"The Expression of Ecto-Nucleotide Pyrophosphatase\/Phosphodiesterase 1 (E-NPP1) Is Correlated with Astrocytic Tumor Grade","volume":"113","author":"Aerts","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"5","key":"2026102305072758400_cit21","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/2159-8290.cd-20-0387","article-title":"Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis","volume":"11","author":"Li","year":"2021","journal-title":"Cancer Discov"},{"issue":"19","key":"2026102305072758400_cit22","doi-asserted-by":"publisher","DOI":"10.1172\/jci186104","article-title":"2024 Lasker Award Recipient Zhijian Chen Elucidates How DNA Stimulates Immunity","volume":"134","author":"Heimberger","year":"2024","journal-title":"J. Clin. Invest."},{"key":"2026102305072758400_cit23","doi-asserted-by":"publisher","first-page":"116211","DOI":"10.1016\/j.ejmech.2024.116211","article-title":"Ecto-Nucleotide Pyrophosphatase\/Phosphodiesterase 1 Inhibitors: Research Progress and Prospects","volume":"267","author":"Guan","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"2026102305072758400_cit24","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70262","article-title":"Inhibition of Ectonucleotide Pyrophosphatase\/Phosphodiesterase 1 (ENPP1): A Medicinal Chemistry Approach at the Crossroad of Immunotherapy and Metabolic Modulation","volume":"359","author":"Rauf","year":"2026","journal-title":"Arch. Pharm."},{"issue":"19","key":"2026102305072758400_cit25","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.3390\/molecules27196175","article-title":"From Myricetin to the Discovery of Novel Natural Human ENPP1 Inhibitors: A Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and MM\/GBSA Study","volume":"27","author":"Song","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"2026102305072758400_cit26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41598-023-50590-7","article-title":"Naturally Occurring Quercetin and Myricetin as Potent Inhibitors for Human Ectonucleotide Pyrophosphatase\/Phosphodiesterase 1","volume":"14","author":"Duangiad","year":"2024","journal-title":"Sci. Rep."},{"key":"2026102305072758400_cit27","doi-asserted-by":"publisher","first-page":"116211","DOI":"10.1016\/j.ejmech.2024.116211","article-title":"Ecto-Nucleotide Pyrophosphatase\/Phosphodiesterase 1 Inhibitors: Research Progress and Prospects","volume":"267","author":"Guan","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"23","key":"2026102305072758400_cit28","doi-asserted-by":"publisher","first-page":"10080","DOI":"10.1021\/jm501434y","article-title":"Imidazopyridine- and Purine-Thioacetamide Derivatives: Potent Inhibitors of Nucleotide Pyrophosphatase\/Phosphodiesterase 1 (NPP1)","volume":"57","author":"Chang","year":"2014","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026102305072758400_cit29","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.chembiol.2020.07.007","article-title":"Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP","volume":"27","author":"Carozza","year":"2020","journal-title":"Cell Chem. Bio."},{"issue":"9","key":"2026102305072758400_cit30","doi-asserted-by":"publisher","first-page":"102336","DOI":"10.1016\/j.xcrm.2025.102336","article-title":"ENPP1 Inhibitor with Ultralong Drug-Target Residence Time as an Innate Immune Checkpoint Blockade Cancer Therapy","volume":"6","author":"Wang","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"5","key":"2026102305072758400_cit31","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1021\/acs.jmedchem.3c02288","article-title":"Discovery of Pyrido[2,3-d]Pyrimidin-7-One Derivatives as Highly Potent and Efficacious Ectonucleotide Pyrophosphatase\/Phosphodiesterase 1 (ENPP1) Inhibitors for Cancer Treatment","volume":"67","author":"Sun","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026102305072758400_cit32","doi-asserted-by":"publisher","first-page":"116853","DOI":"10.1016\/j.ejmech.2024.116853","article-title":"Discovery of Orally Bioavailable Phosphonate Prodrugs of Potent ENPP1 Inhibitors for Cancer Treatment","volume":"279","author":"Gao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"2026102305072758400_cit33","unstructured":"Gallatin, W. M.; Odingo, J.; Dietsch, G. N.; Florio, V.; Venkateshappa, C.; Duraiswamy, A. J.\n          Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof, WO 2019046778 A1, 2019."},{"issue":"22","key":"2026102305072758400_cit34","doi-asserted-by":"publisher","first-page":"15141","DOI":"10.1021\/acs.jmedchem.3c01061","article-title":"Discovery of Orally Bioavailable Phthalazinone Analogues as an ENPP1 Inhibitor for STING-Mediated Cancer Immunotherapy","volume":"66","author":"Cho","year":"2023","journal-title":"J. Med. Chem."},{"issue":"20","key":"2026102305072758400_cit35","doi-asserted-by":"publisher","first-page":"18317","DOI":"10.1021\/acs.jmedchem.4c01634","article-title":"Discovery of Imidazo[1,2-a]Pyrazine Derivatives as Potent ENPP1 Inhibitors","volume":"67","author":"Zhan","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026102305072758400_cit36","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1038\/s41467-025-59874-0","article-title":"Oral ENPP1 Inhibitor Designed Using Generative AI as next Generation STING Modulator for Solid Tumors","volume":"16","author":"Pu","year":"2025","journal-title":"Nat. Commun."},{"key":"2026102305072758400_cit37","doi-asserted-by":"publisher","first-page":"118666","DOI":"10.1016\/j.ejmech.2026.118666","article-title":"Discovery of Novel ENPP1 Inhibitors with Benzotriazole Core for Cancer Immunotherapy","volume":"307","author":"Choi","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"2026102305072758400_cit38","unstructured":"ClinicalTrials.gov identifier for RBS2418: NCT05270213; https:\/\/clinicaltrials.gov\/study\/NCT05270213 (accessed April 30, 2026)."},{"key":"2026102305072758400_cit39","unstructured":"ClinicalTrials.gov identifier for TXN10128: NCT05978492. https:\/\/clinicaltrials.gov\/study\/NCT05978492 (accessed April 30, 2026)."},{"key":"2026102305072758400_cit40","unstructured":"ClinicalTrials.gov identifier for SR-8541A: NCT06063681; https:\/\/clinicaltrials.gov\/study\/NCT06063681 (accessed April 30, 2026)."},{"key":"2026102305072758400_cit41","unstructured":"ClinicalTrials.gov identifier for ZX-8177: NCT07310134; https:\/\/clinicaltrials.gov\/study\/NCT07310134 (accessed April 30, 2026)."},{"key":"2026102305072758400_cit42","unstructured":"ClinicalTrials.gov identifier for ISM5939: NCT06724042; https:\/\/clinicaltrials.gov\/study\/NCT06724042 (accessed April 30, 2026)."},{"issue":"5","key":"2026102305072758400_cit43","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1021\/acs.jmedchem.5c03600","article-title":"Harnessing Unique Boron Chemistry to Develop a New Class of Non-Hydroxamate HDAC Inhibitors with Validated In Vivo Efficacy","volume":"69","author":"Zhou","year":"2026","journal-title":"J. Med. Chem."},{"issue":"24","key":"2026102305072758400_cit44","doi-asserted-by":"publisher","first-page":"17706","DOI":"10.1021\/acs.jmedchem.1c01691","article-title":"Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores","volume":"64","author":"Xiao","year":"2021","journal-title":"J. Med. Chem."},{"issue":"8","key":"2026102305072758400_cit45","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1021\/acsptsci.5c00238","article-title":"Recent Development of Boron-Containing Small-Molecule Anticancer Agents","volume":"8","author":"Guo","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"5","key":"2026102305072758400_cit46","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/0008-5472.can-12-2796","article-title":"Acidity Generated by the Tumor Microenvironment Drives Local Invasion","volume":"73","author":"Estrella","year":"2013","journal-title":"Cancer Res."},{"issue":"20","key":"2026102305072758400_cit47","doi-asserted-by":"publisher","first-page":"9254","DOI":"10.1021\/acs.jmedchem.9b01213","article-title":"Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer","volume":"62","author":"Kawaguchi","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026102305072758400_cit48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11302-005-5303-4","article-title":"Modulation of Purinergic Signaling by NPP-Type Ectophosphodiesterases","volume":"2","author":"Stefan","year":"2006","journal-title":"Purinergic Signal."},{"issue":"2","key":"2026102305072758400_cit49","doi-asserted-by":"publisher","first-page":"101526","DOI":"10.1016\/j.jbc.2021.101526","article-title":"Structure and Function of the Ecto-Nucleotide Pyrophosphatase\/Phosphodiesterase (ENPP) Family: Tidying up Diversity","volume":"298","author":"Borza","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"7","key":"2026102305072758400_cit50","doi-asserted-by":"publisher","first-page":"110013","DOI":"10.1016\/j.celrep.2021.110013","article-title":"Autotaxin Impedes Anti-Tumor Immunity by Suppressing Chemotaxis and Tumor Infiltration of CD8+ T Cells","volume":"37","author":"Matas-Rico","year":"2021","journal-title":"Cell Rep."},{"issue":"52","key":"2026102305072758400_cit51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2313693120","article-title":"ENPP1 Is an Innate Immune Checkpoint of the Anticancer cGAMP-STING Pathway in Breast Cancer","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"2026102305072758400_cit52","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and Function of the cGAS-STING Pathway of Cytosolic DNA Sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"2026102305072758400_cit53","doi-asserted-by":"publisher","first-page":"116006","DOI":"10.1016\/j.bcp.2023.116006","article-title":"Targeting ENPP1 for Cancer Immunotherapy: Killing Two Birds with One Stone","volume":"220","author":"Huang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"2026102305072758400_cit54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-7240-1_6","article-title":"Detection of Cyclic Dinucleotides by STING","volume-title":"c-di-GMP Signaling: Methods and Protocols","author":"Du","year":"2017"},{"issue":"4","key":"2026102305072758400_cit55","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/med.22016","article-title":"cGAS-STING Pathway Agonists Are Promising Vaccine Adjuvants","volume":"44","author":"Tian","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"14","key":"2026102305072758400_cit56","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1111\/febs.70102","article-title":"Oxaliplatin Accelerates Immunogenic Cell Death by Activating the cGAS\/STING\/TBK1\/IRF5 Pathway in Gastric Cancer","volume":"292","author":"Zhao","year":"2025","journal-title":"FEBS J"},{"issue":"4","key":"2026102305072758400_cit57","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic Death of Colon Cancer Cells Treated with Oxaliplatin","volume":"29","author":"Tesniere","year":"2010","journal-title":"Oncogene"},{"issue":"5","key":"2026102305072758400_cit58","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41401-023-01210-7","article-title":"Second Messenger 2\u20193\u2019-Cyclic GMP-AMP (2\u20193\u2019-cGAMP): The Cell Autonomous and Non-Autonomous Roles in Cancer Progression","volume":"45","author":"Ma","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"2026102305072758400_cit59","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1158\/1078-0432.ccr-22-1681","article-title":"ENPP1 Immunobiology as a Therapeutic Target","volume":"29","author":"Ruiz-Ferna\u0301ndez De Co\u0301rdoba","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"2026102305072758400_cit60","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2\u20323\u2032-cGAMP by ENPP1 and Design of Nonhydrolyzable Analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat. Chem. Biol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01649","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24096\/68782387\/jm6c01649.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24096\/68782387\/jm6c01649.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:21:16Z","timestamp":1792747276000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/24096\/5446787\/Development-of-pH-Resilient-Boronic-Acid-ENPP1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":60,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,10,8]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01649","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01649.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01649.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01649.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01649.s004","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}